Loading company…
Panarum develops oral polypeptide therapies and a formulation platform for delivering active ingredients.
Panarum is a pharmaceutical research and development company offering oral polypeptide therapies. Its patented Proteoral® platform protects active ingredients in capsules and releases them in the small intestine, and the company provides technical transfer support for manufacturing. Founded in 2016 and based in Delaware, it raised USD 0.64 million in venture funding from Cygnus Capital in February 2021. Milena Batalla is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in